GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 78 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $483,282 | +55.9% | 20,221 | -4.8% | 0.01% | +40.0% |
Q4 2020 | $310,075 | +2.8% | 21,238 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $301,580 | -3.5% | 21,238 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $312,411 | +296.9% | 21,238 | +11.2% | 0.01% | +200.0% |
Q1 2020 | $78,704 | -12.3% | 19,103 | +2.4% | 0.00% | +100.0% |
Q4 2019 | $89,759 | -21.8% | 18,661 | -1.5% | 0.00% | -50.0% |
Q3 2019 | $114,789 | -6.6% | 18,942 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $122,933 | +6.1% | 18,942 | +15.9% | 0.00% | 0.0% |
Q1 2019 | $115,851 | +28.6% | 16,340 | -11.8% | 0.00% | 0.0% |
Q4 2018 | $90,056 | -33.9% | 18,530 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $136,196 | -99.9% | 18,530 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $118,221,000 | +17.3% | 18,530 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $100,803,000 | +29990.4% | 18,530 | -46.7% | 0.00% | -50.0% |
Q3 2017 | $335,000 | -2.3% | 34,773 | +19.9% | 0.00% | 0.0% |
Q2 2017 | $343,000 | -7.8% | 29,013 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $372,000 | +4.8% | 29,013 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $355,000 | +14.1% | 29,013 | +10.2% | 0.00% | +50.0% |
Q3 2016 | $311,000 | +21.5% | 26,324 | -10.7% | 0.00% | 0.0% |
Q2 2016 | $256,000 | +48.0% | 29,465 | -10.3% | 0.00% | +100.0% |
Q1 2016 | $173,000 | -20.6% | 32,862 | +16.8% | 0.00% | -50.0% |
Q4 2015 | $218,000 | -1.4% | 28,128 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $221,000 | -10.9% | 28,128 | +2.6% | 0.00% | 0.0% |
Q2 2015 | $248,000 | -37.4% | 27,418 | -10.1% | 0.00% | -33.3% |
Q1 2015 | $396,000 | -4.6% | 30,488 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $415,000 | +52.0% | 30,488 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $273,000 | -33.9% | 30,488 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $413,000 | +36.3% | 30,488 | 0.0% | 0.00% | +50.0% |
Q1 2014 | $303,000 | -25.4% | 30,488 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $406,000 | +33.6% | 30,488 | +22.0% | 0.00% | +50.0% |
Q3 2013 | $304,000 | +19.7% | 24,981 | +1.6% | 0.00% | 0.0% |
Q2 2013 | $254,000 | – | 24,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |